JPH029384A - Production of l-glutamic acid by fermentation process - Google Patents

Production of l-glutamic acid by fermentation process

Info

Publication number
JPH029384A
JPH029384A JP15975088A JP15975088A JPH029384A JP H029384 A JPH029384 A JP H029384A JP 15975088 A JP15975088 A JP 15975088A JP 15975088 A JP15975088 A JP 15975088A JP H029384 A JPH029384 A JP H029384A
Authority
JP
Japan
Prior art keywords
glutamic acid
culture
gramicidin
acid
strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP15975088A
Other languages
Japanese (ja)
Inventor
Rei Furukawa
令 古川
Masatoshi Ishimura
石村 正利
Toshihide Nakanishi
中西 俊秀
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Priority to JP15975088A priority Critical patent/JPH029384A/en
Priority to CN 89106345 priority patent/CN1039442A/en
Publication of JPH029384A publication Critical patent/JPH029384A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To industrially obtain L-glutamic acid at low cost by culture of specific microorganisms tolerant to a specific antibiotic. CONSTITUTION:L-glutamic acid-productive bacteria tolerant to gramicidin, classified as Corynegacterium or Brevibacterium sp. is put to culture in a culture medium to produce and accumulate L-glutamic acid in the resultant cultured product and collect this L-glutamic acid. The above-mentioned mutant tolerant to gramicidin can be obtained by induction from L-glutamic acid-productive bacteria classified as Corynebacterium or Brevibacterium sp., or by imparting bacteria having the above nature with L-glutamic acid productivity.

Description

【発明の詳細な説明】 産業上の利用分野 本発明は発酵法によるし一グルタミン酸の製造法に関す
る。その目的は、食品添加物等として利用される重要な
アミノ酸であるL−グルタミン酸を工業的に安価に製造
することにある。
DETAILED DESCRIPTION OF THE INVENTION Field of the Invention The present invention relates to a method for producing monoglutamic acid by fermentation. The purpose is to industrially produce L-glutamic acid, which is an important amino acid used as a food additive, at low cost.

従来の技術 従来、発酵法によるし一グルタミン酸の製造法に関して
は、コリネバクテリウム属、ブレビバクテリウム属の野
生株あるいは、種々の物質を生育に要求するか又は種々
の物質に耐性を有する変異株を用いる方法が知られてい
る。また、エネルギー代謝阻害を示す抗生物質またはユ
ビキノンの生合成の前駆体に耐性を示し、L−グルタミ
ン酸生産能を有する微生物を用いる方法(特開昭59−
15.4995)が知られている。
Conventional technology Conventionally, for the production of monoglutamic acid by fermentation, wild strains of the genus Corynebacterium and Brevibacterium or mutant strains that require various substances for growth or are resistant to various substances have been used. A method using . In addition, a method using microorganisms that are resistant to antibiotics that inhibit energy metabolism or precursors of ubiquinone biosynthesis and that has the ability to produce L-glutamic acid (Japanese Patent Laid-Open No. 59-1979-1)
15.4995) is known.

発明が解決しようとする課題 食品添加物等として有用なし一グルタミン酸の安価な製
造法が求められている。
Problems to be Solved by the Invention There is a need for an inexpensive method for producing monoglutamic acid, which is not useful as a food additive or the like.

、′J!題を解決するための手段 本発明社らは、L−グルタミン酸を高収率で得るために
より(衾れたL−グルタミン酸生7帝菌の研究を行った
。その結果、エネルギー代謝阻害剤として知られている
各種抗生物質の耐性株の中で、特にグラミシジンに耐性
を有する変異株が高収率で、L−グルタミン酸を生産す
ることを見出し本発明を完成させた。
,'J! In order to obtain L-glutamic acid in high yield, the present inventors conducted research on seven bacteria that produce L-glutamic acid. Among the various antibiotic-resistant strains that have been identified, the present invention was completed by discovering that a mutant strain that is particularly resistant to gramicidin produces L-glutamic acid at a high yield.

以下、本発明を具体的に説明する。The present invention will be explained in detail below.

本発明は、コリネバクテリウム属またはプレビバクテリ
ウム属に属し、グラミシジンに耐性を有し、かつL−グ
ルタミン酸生産能を有する微生物を培地に培養し、培養
物中にL−グルタミン酸を生成蓄積せしめ、該培養物よ
りL−グルタミン酸を採取することを特徴とする発酵法
によるL−グルタミン酸の製造法を提供する。
The present invention involves culturing a microorganism belonging to the genus Corynebacterium or the genus Previbacterium, resistant to gramicidin, and capable of producing L-glutamic acid in a medium, producing and accumulating L-glutamic acid in the culture, Provided is a method for producing L-glutamic acid by a fermentation method, which is characterized in that L-glutamic acid is collected from the culture.

本発明に使用する微生物の例としては、コリネバクテリ
ウム属またはブレビバクテリウム属に属し、グラミシジ
ン耐性を有し、かつL−グルタミン酸生産能を有する微
生物であればいずれも用いることができる。
As an example of the microorganism used in the present invention, any microorganism that belongs to the genus Corynebacterium or Brevibacterium, has resistance to gramicidin, and has L-glutamic acid producing ability can be used.

本変異株は、コリネバクテリウム属またはブレビバクテ
リウム属のし一グルタミン酸生産性細菌から誘導するこ
とにより、あるいは、上記性質を有する菌にL−グルタ
ミン酸生産性を付与することによって得られる。
This mutant strain can be obtained by deriving from a monoglutamic acid-producing bacterium of the genus Corynebacterium or Brevibacterium, or by imparting L-glutamic acid productivity to a bacterium having the above properties.

例えば、L−グルタミン酸生産菌コリネバクテリウム・
グルタミクムATCC−13032をX線、紫外線、コ
バルト等の照射あるいは薬剤、例えば、N−メチル−N
′−二トローN−二トロングアニジンに接触せし袷る等
の通常の変異誘導方法が適宜適用できる。
For example, L-glutamic acid producing bacteria Corynebacterium
Glutamicum ATCC-13032 is irradiated with X-rays, ultraviolet rays, cobalt, etc., or treated with drugs such as N-methyl-N.
Conventional mutagenesis methods such as contacting with '-nitro-N-nitro-longanidine can be applied as appropriate.

変異処理した菌体から変異株を分離する方法は、親株が
生育できない量のグラミシジンを含む固体培地中に生育
できるような菌株を採取するこきにより行われる。
A method for isolating a mutant strain from cells subjected to mutation treatment is to collect a strain that can grow in a solid medium containing an amount of gramicidin in which the parent strain cannot grow.

以下に変異株の取得方法の具体例を示す。A specific example of how to obtain a mutant strain is shown below.

コリネバクテリウム・グルタミクムATCC13032
にN−メチル−N′−二トローN−二トロングアニジン
による通常の変異処理(200mg/j’、30℃、3
0分間)を行った後、lO鱈/m Iのグラミシジンを
含む最小培地〔グルコース10g/β、塩化アンモニウ
ム4g/j!、KH2PO。
Corynebacterium glutamicum ATCC13032
was subjected to the usual mutation treatment with N-methyl-N'-nitro-N-nitroguanidine (200 mg/j', 30°C, 3
0 min), followed by minimal medium containing lO cod/m I of gramicidin [glucose 10 g/β, ammonium chloride 4 g/j! , KH2PO.

Ig#、に2HPO43g/It、Mg5O,・7H2
00,01g/j!、Fe50.・7H,OO,01g
/12.MnSO4’4HzOOlo 1 g/1.尿
素2g/j!、ビオチン50■/I!、寒天20 g/
It。
Ig#, 2HPO43g/It, Mg5O, 7H2
00,01g/j! , Fe50.・7H,OO,01g
/12. MnSO4'4HzOOlo 1 g/1. Urea 2g/j! , Biotin 50■/I! , agar 20 g/
It.

p H7,2)に塗布する。30℃で2〜6日培養し、
生育してくるグラミシジン耐性のコロニーを取得する。
Apply at pH 7.2). Cultured at 30°C for 2 to 6 days,
Obtain gramicidin-resistant colonies that grow.

グラミシジンはシグマ社製(グラミシジンDまたはグラ
ミシジンNFともよばれる)を使用する。グラミシジン
の耐性株50株を釣菌し、親株よりL−グルタミン酸生
産能が向上した菌株を分離する。代表的な菌株として、
コリネバクテリウム・グルタミクムH−7110があげ
られる。
Gramicidin manufactured by Sigma (also called Gramicidin D or Gramicidin NF) is used. Fifty strains resistant to gramicidin were harvested, and strains with improved L-glutamic acid production ability than the parent strain were isolated. As a representative strain,
Examples include Corynebacterium glutamicum H-7110.

本菌株1よ、昭和63年5月11日付で、工業技術院微
生物工業技術研究所にFERM BP−1876として
寄託されている。
This strain 1 was deposited as FERM BP-1876 with the Institute of Microbial Technology, Agency of Industrial Science and Technology on May 11, 1986.

本発明で用いる培地としては、炭素源、窒素源。The culture medium used in the present invention includes a carbon source and a nitrogen source.

無機物、その他使用菌株の必要とする微1の栄養素を捏
良く含有するものであれば合成培地および天然培地のい
ずれも使用できる。
Both synthetic and natural media can be used as long as they contain inorganic substances and other micronutrients required by the strain used.

すなわち炭素源としてはグルコース、フラクトース、シ
ークロース、マルトース、マンノース。
In other words, carbon sources include glucose, fructose, sucrose, maltose, and mannose.

ンルビトール等の炭水化物、糖アルコール、グリセロー
ル、′il粉、澱粉加水分解物、糖蜜などが使用でき、
また酢酸、ピルビン酸、乳酸、フマール酸、グルコン酸
等の有機酸、およびアスパラギン酸などのアミノ酸類、
あるいはエタノールなどの低級アルコールも使用できる
Carbohydrates such as nlubitol, sugar alcohols, glycerol, 'il powder, starch hydrolysates, molasses, etc. can be used.
In addition, organic acids such as acetic acid, pyruvic acid, lactic acid, fumaric acid, and gluconic acid, and amino acids such as aspartic acid,
Alternatively, lower alcohols such as ethanol can also be used.

窒素源としては、アンモニア、塩化アンモニウム、硫酸
アンモニウム、炭酸アンモニウム、リン酸アンモニウム
、酢酸アンモニウムなどの各種無機および有機アンモニ
ウム塩類、あるいはアスパラギン酸などのアミノ酸類、
尿素および窒素含有物質、例えばペプトン、肉エキス、
コーン・ステイープ・リカー、カゼイン加水分解物、大
豆の加水分解物などの種々のものが使用できる。
Nitrogen sources include various inorganic and organic ammonium salts such as ammonia, ammonium chloride, ammonium sulfate, ammonium carbonate, ammonium phosphate, ammonium acetate, or amino acids such as aspartic acid,
urea and nitrogen-containing substances such as peptone, meat extracts,
Various products can be used, such as corn steep liquor, casein hydrolyzate, and soybean hydrolyzate.

無機物としてはリン酸二水素カリウム、リン酸水素二カ
リウム、硫酸マグネシウム、塩化す) IJウム、硫酸
第一鉄、硫酸マンガンおよび炭酸カルシウム等が用いら
れる。
As the inorganic substances, potassium dihydrogen phosphate, dipotassium hydrogen phosphate, magnesium sulfate, sodium chloride, ferrous sulfate, manganese sulfate, calcium carbonate, etc. are used.

さらに、必要に応じてビオチン、ニコチンアミド、パン
トテン酸、サイアミン等の微生物の生育に必要なビタミ
ン類も使用されるが、これらの物質は前記のような他の
培地組成に伴って培地に供されれば、特に加えなくても
よい。
Furthermore, vitamins necessary for the growth of microorganisms, such as biotin, nicotinamide, pantothenic acid, and thiamine, are also used as necessary, but these substances are provided in the medium along with the other medium compositions mentioned above. If so, there is no need to add it.

培養は振盪培養または深部通気攪拌培養などの好気的条
件下で行う。培養は温度20〜40℃で、pH3〜9の
範囲で、好ましくは中性付近に保持する。培地のpH調
整は臭酸カルシウム、有機または無機の酸、アルカリ溶
液、アンモニア、pH緩所液などによって行う。培養時
間は通常1〜4日間で培養液中にL−グルタミン酸が生
成M積する。
Cultivation is performed under aerobic conditions such as shaking culture or deep aeration agitation culture. The culture is maintained at a temperature of 20 to 40°C and a pH in the range of 3 to 9, preferably around neutrality. The pH of the culture medium is adjusted using calcium bromate, an organic or inorganic acid, an alkaline solution, ammonia, a pH reducing solution, or the like. The culture time is usually 1 to 4 days, and L-glutamic acid is produced in the culture solution.

またL−グルタミン酸を蓄晴させるため、従来知られて
いるように、ビオチン咄を低く抑えたり、ビオチン含有
1の高い培地の場合には界面活性剤。
In addition, in order to accumulate L-glutamic acid, as is conventionally known, biotin powder should be kept low, or in the case of a medium with a high biotin content, a surfactant should be used.

ペニシリン等を添加してもよい。Penicillin etc. may be added.

培ff終了後、培養液よりL−グルタミン酸を採取する
には、培養液より菌体などの固形分を除去し、公知のイ
オン交換処理法、a縮性、吸着法。
After culturing, to collect L-glutamic acid from the culture solution, solids such as bacterial cells are removed from the culture solution, and a known ion exchange treatment method, acondensation method, and adsorption method are used.

塩析法などを併用することにより、培養液からLグルタ
ミン酸を回収することができる。
L-glutamic acid can be recovered from the culture solution by using a salting-out method or the like.

以下、実施例をあげて本発明を具体的に説明する。Hereinafter, the present invention will be specifically explained with reference to Examples.

実施例1゜ 種菌としてコリネバクテリウム・グルタミクムH−71
10(FERM  BP−1876)株を用いた。H−
7110株をグルコース40g/I!。
Example 1 Corynebacterium glutamicum H-71 as inoculum
10 (FERM BP-1876) strain was used. H-
7110 strain with glucose 40g/I! .

酵母エキス5g/l、KH2PO41,5g/I!。Yeast extract 5g/l, KH2PO41.5g/I! .

K2HPO40,5g/n、Mg SO+・7H200
,5g#、ビオチン100g/L尿素3 g/I!。
K2HPO40,5g/n, MgSO+・7H200
, 5g#, biotin 100g/L urea 3g/I! .

p H7,2の組成の種培地20亀1を含む25 Qm
l容の三角フラスコで24時間、振盪培養した。得られ
た種培養液1+++lを2 Qmlの下記発酵培地を含
む25 Qml容の三角フラスコに植菌し、30℃。
Seed medium with a composition of pH 7.2 containing 20 ml of 25 Qm
The cells were cultured with shaking in a 1-volume Erlenmeyer flask for 24 hours. 1+++l of the obtained seed culture solution was inoculated into a 25 Qml Erlenmeyer flask containing 2 Qml of the following fermentation medium, and incubated at 30°C.

24時間振盪培養を行った。その時のし一グルタミン酸
生産量は28.1g/j!であった。対照として親株Δ
TCC−13032を用いて同様に培養した結果、L−
グルタミン酸の生産量は24.4 g/7!であった。
Shaking culture was performed for 24 hours. The production amount of monoglutamic acid at that time was 28.1g/j! Met. Parent strain Δ as control
As a result of culturing in the same manner using TCC-13032, L-
The production amount of glutamic acid is 24.4 g/7! Met.

また、グラミシジン耐性株の取得と同様の変異処理によ
り得られた他のエネルギー代謝阻害を示す抗生物質であ
るオリゴマイシン。
Additionally, the acquisition of gramicidin-resistant strains and oligomycin, an antibiotic that exhibits other energy metabolism inhibition, were obtained through similar mutational treatments.

アンチマイシンA、ルタマイシン9パリノマイシン、グ
ラミシジンSのそれぞれの耐性株M−3482゜M−3
488,M−3490,M−3497,M−3499に
ついても、同様に培養を行い、L−グルタミン酸の生産
量を測定した。その結果を第1表に示す。
Antimycin A, lutamycin 9 palinomycin, and gramicidin S resistant strains M-3482゜M-3
488, M-3490, M-3497, and M-3499 were similarly cultured, and the amount of L-glutamic acid produced was measured. The results are shown in Table 1.

発酵培地の組成: 糖蜜(糖換算)50g/ffi、NH4H,PO41g
 / R,(N H+)zHP 04 1 g / j
! 、 (N H4)2 S 042 g / i’ 
、尿素5 g/l、 Mn 504−4H2010vg
/ 1!、  Ca CO330g/ j!、ペニシリ
ンG5 un+ts7ml (p H6,5)第   
 1    表 ::l’J  Jt−抗生物質耐性(濃度) L−グル
タ’、l−131!!2  オリゴマイシン (0,1
mg/ml)’、i−FL3g  アンチマイシンA 
(0,1mg/ff+l)X: −3490ルクマイシ
ン  (0,1zg/if)M−3197バリノマイ/
ン (0,1mg/ml)M−3499グラミンジンS
   (10xr/m1)1(−7110グラミシジン
  (10埒/ml)、へ T  CC−13032 実施例2゜ ミン酸軸/2) 26.3 25.4 25.2 25.3 26.6 24.3 種菌として、コリネバクテリウム・グルタミクムH−7
110(FERM  BP−1376)株を用いた。実
施例1と同様の種培地にH−7110株を培養して得ら
れた種培養液39m1を、下記組成の発酵培地80 Q
mlを含む22ジャーファーメンタ−に殖菌し、通気i
 l VVIII、 1拌数800rpm。
Composition of fermentation medium: Molasses (sugar equivalent) 50g/ffi, NH4H, PO41g
/ R, (NH+)zHP 04 1 g / j
! , (NH4)2 S 042 g/i'
, urea 5 g/l, Mn 504-4H2010vg
/ 1! , Ca CO330g/j! , penicillin G5 un+ts 7ml (pH 6,5)
1 Table: :l'J Jt-Antibiotic Resistance (Concentration) L-Gluta', l-131! ! 2 Oligomycin (0,1
mg/ml)', i-FL3g antimycin A
(0,1mg/ff+l)X: -3490 Lucumycin (0,1zg/if)M-3197 Valinomycin
(0.1mg/ml) M-3499 Gramingin S
(10xr/ml) 1 (-7110 gramicidin (10 ml/ml), T CC-13032 Example 2 mic acid axis/2) 26.3 25.4 25.2 25.3 26.6 24.3 As an inoculum, Corynebacterium glutamicum H-7
110 (FERM BP-1376) strain was used. 39 ml of the seed culture solution obtained by culturing the H-7110 strain in the same seed medium as in Example 1 was added to the fermentation medium 80Q with the following composition.
Incubate the bacteria in a 22-jar fermentor containing ml and aerate.
l VVIII, 1 stirring number 800 rpm.

p H7,6(アンモニア水により調整)で培養を行っ
た。
Culture was performed at pH 7.6 (adjusted with aqueous ammonia).

培地中の糖が消費され、p Hが上昇時に、ペリ/リン
Gを5units/mlになるように添加後、40%の
砧を含む加水糖蜜を連続的に添加しながら、43時間の
培養を行った。対照として、親株、へTCC−1303
2株を用いて、同様に培養を行った。H−7]10株及
びATCC−13032株でのグルタミン酸i4:産1
を第2表に示す。
When the sugar in the medium was consumed and the pH rose, Peri/Lin G was added to 5 units/ml, and then cultured for 43 hours while continuously adding hydrated molasses containing 40% minuta. went. As a control, the parent strain, TCC-1303
Culture was performed in the same manner using two strains. H-7] Glutamic acid i4: production 1 in 10 strains and ATCC-13032 strain
are shown in Table 2.

発酵培地の組成: 糖蜜(iFi換算)30g/l、NH,H2PO。Composition of fermentation medium: Molasses (iFi equivalent) 30g/l, NH, H2PO.

1.21?/L  (NH9)zHP○、  1.2g
/i’。
1.21? /L (NH9)zHP○, 1.2g
/i'.

Mn5O,・4〜6H20100g/l。Mn5O, 4~6H20100g/l.

Cu SO= ・5H2020g/ 1 (pH7,6
)第 表 菌 株 L−グルタミン酸軸/β) 対糖収率(%) ΔT CC−13032 発明の効果 本発明により、 収率よくL−グルタミン酸を得 ることかできる。
Cu SO= ・5H2020g/1 (pH7,6
) Table 1 Bacterial Strain L-Glutamic Acid Axis/β) Sugar Yield (%) ΔT CC-13032 Effects of the Invention According to the present invention, L-glutamic acid can be obtained in good yield.

Claims (1)

【特許請求の範囲】[Claims] コリネバクテリウム属またはブレビバクテリウム属に属
し、グラミシジンに耐性を有し、L−グルタミン酸生産
能を有する微生物を培地に培養し、培養物中にL−グル
タミン酸を生成蓄積せしめ、これを採取することを特徴
とする発酵法によるL−グルタミン酸の製造法。
Cultivating a microorganism belonging to the genus Corynebacterium or Brevibacterium, resistant to gramicidin, and capable of producing L-glutamic acid in a medium, producing and accumulating L-glutamic acid in the culture, and collecting the same. A method for producing L-glutamic acid by a fermentation method, characterized by:
JP15975088A 1988-06-28 1988-06-28 Production of l-glutamic acid by fermentation process Pending JPH029384A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP15975088A JPH029384A (en) 1988-06-28 1988-06-28 Production of l-glutamic acid by fermentation process
CN 89106345 CN1039442A (en) 1988-06-28 1989-06-28 Produce the method for L-L-glutamic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15975088A JPH029384A (en) 1988-06-28 1988-06-28 Production of l-glutamic acid by fermentation process

Publications (1)

Publication Number Publication Date
JPH029384A true JPH029384A (en) 1990-01-12

Family

ID=15700444

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15975088A Pending JPH029384A (en) 1988-06-28 1988-06-28 Production of l-glutamic acid by fermentation process

Country Status (2)

Country Link
JP (1) JPH029384A (en)
CN (1) CN1039442A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1035727C (en) * 1991-04-02 1997-08-27 黄文涛 Fermentation technology of L-glutamic acid
JP3880636B2 (en) * 1994-01-10 2007-02-14 味の素株式会社 Method for producing L-glutamic acid by fermentation
DE69535643D1 (en) * 1994-08-19 2007-12-27 Ajinomoto Kk Process for the fermentative production of L-lysine and L-glutamic acid
CN100999756B (en) * 2006-12-18 2010-06-02 浙江大学 Process of preparing gamma-polyglutamic acid by bacillus subtilis and glutamic acid bacillus mixed cultivating system

Also Published As

Publication number Publication date
CN1039442A (en) 1990-02-07

Similar Documents

Publication Publication Date Title
JPH03232497A (en) Production of l-glutamine by fermentation
JPH044887A (en) Fermentative production of l-lysine
JP2004516833A (en) Corynebacterium ammoniagenes CJIP009, a microorganism that produces 5'-inosinic acid in high yield, and method for producing 5'-inosinic acid using the same
JPS6257315B2 (en)
US5650304A (en) Process for producing L-lysine by fermentation
JPH08322583A (en) Production of l-isoleucine by fermentation method
JPH06133787A (en) Production of l-isoleucine by fermentation
IE69844B1 (en) Microbiological process for the preparation of 6-hydroxypicolinic acid
JPH029384A (en) Production of l-glutamic acid by fermentation process
JP2578463B2 (en) Production method of L-lysine by fermentation method
JP2578474B2 (en) Method for producing L-glutamic acid
CA1215338A (en) Process for producing l-glutamic acid by fermentation
JPH057493A (en) Production of l-valine by fermentation
JPS63248392A (en) Production of l-leucine by fermentation
JPS59113894A (en) Preparation of l-glutamic acid by fermentation
JPS61119194A (en) Production of l-ornithine through fermentation process
KR0146493B1 (en) Process for producing l-alanine by fermentation
HU215248B (en) Process for producing l-lysine
JPH055476B2 (en)
JPS5811198B2 (en) Hatsukouhou Niyoru Urokanin Sanno Seizouhou
JPS61139398A (en) Production of l-glutamic acid
JPS59154994A (en) Preparation of amino acid by fermentation
JPH0692A (en) Production of l-arginine by fermentation method
JPS5988094A (en) Production of l-lysine by fermentation
JPH045437B2 (en)